In the current landscape of modern medicine, Clinical Genomic Solutions have transitioned from experimental research tools to the backbone of diagnostic precision. As a premier hub for molecular innovation, Shenzhen BioX Medical Co., Ltd. (Established 2017) represents the pinnacle of Chinese high-tech manufacturing in the IVD (In Vitro Diagnostics) sector. Operating from a 9,000 square meter state-of-the-art facility in Shenzhen, BioX Medical integrates cutting-edge automation with genomic insights to serve over 120 countries.
The global shift toward Precision Healthcare demands more than just hardware; it requires a synergy of rapid throughput, analytical sensitivity, and rigorous compliance. Our role as a leading manufacturer and supplier is defined by our ability to provide Information Gain—delivering diagnostic systems that do not merely collect data, but translate complex biological signals into actionable clinical decisions.
Located in Shenzhen, the "Silicon Valley of Hardware," BioX Medical leverages a unique 1-hour supply chain circle. This allows us to source high-precision optical components, microfluidic chips, and semiconductor elements with unparalleled speed and cost-efficiency. For global procurement officers, this translates to reduced lead times and highly competitive pricing without compromising on the stringent requirements of medical-grade engineering.
Our platforms, such as the Mindray Mn2880 and Biobase Leia-X4, represent the "Sample-to-Result" philosophy. We minimize human error by integrating extraction, amplification, and detection into a single, closed-loop workflow.
The Chromosome Karyotype Analysis System utilizes AI-driven high-resolution imaging to automate the identification of genetic abnormalities, significantly reducing the workload of clinical pathologists.
Every device is manufactured under ISO 13485 standards. We provide full documentation support for CE-IVDR, FDA, and local Ministry of Health registrations, ensuring seamless market entry for our partners.
Advanced Peltier technology in our real-time PCR machines ensures temperature uniformity within ±0.1°C, a critical factor for the reproducibility of quantitative results in oncology and infectious disease testing.
We don't just ship boxes. We provide Localization Support including multi-language software interfaces, local technical training, and region-specific reagent validation.
The demand for portable systems like the Tianlong Gentier Mini is skyrocketing. Decentralized testing allows for immediate clinical intervention in remote clinics or emergency settings. BioX Medical is at the forefront of miniaturizing complex optics for these "lab-on-a-chip" applications.
Data volume in genomics is overwhelming. Our future-ready systems are designed with API capabilities to integrate with Cloud-AI platforms, allowing for real-time variant calling and biomarker trend analysis across large populations.
The industry is moving toward "Green Labs." By optimizing the power consumption of LED light sources and reducing reagent waste through high-precision liquid handling (as seen in our Biobase Leia-X4), we help institutions meet ESG goals.
National-scale pathogen monitoring during outbreaks. Our high-throughput PCR systems allow government labs to process thousands of samples daily with full traceability.
Using NGS and real-time PCR for companion diagnostics. Identifying specific genetic mutations allows clinicians to prescribe targeted therapies, improving patient outcomes.
Supporting university labs with flexible, open-platform systems that allow for custom assay development and fundamental biological discovery.
Application of genomic tools in agriculture and livestock management, such as our ELISA Kits for Bovine IBR, ensuring food security and animal health.
Global Logistics
Shipping to 120+ Countries via Shenzhen Port
BioX Medical
